H.R. 8857In Committee
To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.
Key facts
Introduced: May 15, 2026
Chamber: House
Cosponsors: 3
Congress: 119th
Latest action · May 15, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Timeline
- May 15, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- May 15, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- May 15, 2026Introduced in House
- May 15, 2026Introduced in House
Cosponsors
View official record on Congress.gov →
Make your voice heard
Contact your representatives about this bill in under 2 minutes.
📬 Contact Your Reps →